Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Theravance Biopharma R&D IP, LLC”

252 pharma patents match "Theravance Biopharma R&D IP, LLC" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 252
Index total 30,257
Page 11 / 11

Quick answer

This filtered view shows 252 pharmaceutical patents matching "Theravance Biopharma R&D IP, LLC" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

252 results for “Theravance Biopharma R&D IP, LLC” · 30,257 patents in full index Clear search

  1. US 8853255

    3-phenoxymethylpyrrolidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  2. US 8846913

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  3. US 8822522

    Dual-acting pyrazole antihypertensive agents

    Theravance Biopharma R&D IP, LLC · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  4. US 8815907

    Quaternary ammonium compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  5. US 8816091

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance Biopharma R&D IP, LLC · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  6. US 8802857

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  7. US 8802698

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  8. US 8802856

    Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  9. US 8802709

    Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance Biopharma R&D IP, LLC · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  10. US 8791151

    Crystalline form of a 3-phenoxymethylpyrrolidine compound

    Theravance Biopharma R&D IP, LLC · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted
  11. US 8785633

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance Biopharma R&D IP, LLC · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  12. US 8778949

    1-(2-phenoxymethylphenyl)piperazine compounds

    Theravance Biopharma R&D IP, LLC · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted